Trial Profile
Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2011
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary) ; Medroxyprogesterone (Primary) ; Progesterone (Primary)
- Indications Menopausal syndrome
- Focus Pharmacodynamics
- 10 Aug 2011 New trial record
- 22 Jun 2011 Results published in Fertility and Sterility.